EEF1A1 and metabolic dysfunction-associated steatotic liver disease: In Western diet-induced obese mice with MASLD, we observed that inhibition of EEF1A1 with the marine compound didemnin B (DB) reduced hepatic triglyceride accumulation and steatosis (47).